The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Baddley, John W.
Mannion, Melissa L.
Saag, Kenneth G.
Curtis, Jeffrey R.
Funding for this research was provided by:
Agency for Healthcare Research and Quality (U19HS021110)
Text and Data Mining valid from 2016-09-22
Version of Record valid from 2016-09-22
13 May 2016
5 September 2016
22 September 2016